Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Guardion Health Sciences, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 19 | 20 | +1 |
| Shares | 3.01M | 2.49M | −516.2K (−17.2%) |
| Value | $3.82M | $1.61M | −$2.21M (−57.8%) |
New holders (4)
Institutions that held Guardion Health Sciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 61,847 | $40.0K | 0.00% |
| Citigroup Inc | 18,617 | $12.0K | 0.00% |
| Two Sigma Securities, LLC | 11,924 | $8.00K | 0.00% |
| Bank of America Corp | 46 | $0 | 0.00% |
Sold out (3)
Institutions that held Guardion Health Sciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 25,900 | $33.0K |
| Susquehanna International Group, LLP | 22,234 | $28.0K |
| Gerber Kawasaki Wealth & Investment Management | 38 | $0 |